Molgramostim biosimilar (Laboratorios AC Farma)

莫拉司亭生物类似药 (Laboratorios AC Farma)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameMolgramostim biosimilar (Laboratorios AC Farma)
Drug Alias Name莫拉司亭生物仿制药 (Laboratorios AC Farma)MGM-Factor
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokinesBiologics > Biosimilar
Mechanisms of ActionGranulocyte-macrophage colony-stimulating factor receptor stimulants
TargetsGranulocyte-macrophage colony-stimulating factor receptor
Therapy Area/IndicationsNeutropenia
Global Approved IndicationsNeutropenia
Approved Indications in ChinaN/A
Original Approved Country/TerritoryPeru
Original Approved Date2012/01/01
Country/TerritoryPeru
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesLaboratorios Ac Farma
China Registration ClassN/A

Develop Information

Active CompaniesLaboratorios Ac Farma
Inactive CompaniesN/A
Active IndicationsNeutropenia
Inactive IndicationsN/A

Other Information

ATC CodeL03AA03
Related LinksN/A